RIVERA TERÁN V, Isnardi C, De Abreu P, Laurindo I, Alpízar Rodríguez D. OVERLIFE OF BIOLOGIC AND SYNTHETIC TARGETED DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE LATIN AMERICAN COUNTRIES. Invest. Discapacidad [Internet]. 2025 Nov. 11 [cited 2025 Nov. 20];11(S1). Available from: https://dsm.inr.gob.mx/indiscap/index.php/INDISCAP/article/view/536